Improved survival with simendan after experimental myocardial infarction in rats
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference44 articles.
1. Early angiotensin converting enzyme inhibitor therapy after experimental myocardial infarction prevents left ventricular dilation by reducing infarct expansion: a possible mechanism of clinical benefits;Ali;Coron. Artery. Dis.,1998
2. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals;Alousi;J. Cardiovasc. Pharmacol.,1983
3. Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy;Bonarjee;Am. J. Cardiol.,1993
4. Physiologic basis of vasodilator therapy for heart failure;Cohn;Am. J. Med.,1981
5. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials;Domanski;J. Am. Coll. Cardiol.,1999
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of Intravenous Levosimendan or Milrinone on Left Atrial Pressure in Patients Undergoing Off-Pump Coronary Artery bypass Grafting—A Prospective Double-Blind, Randomized Controlled Trial;Annals of Cardiac Anaesthesia;2023
2. Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study;Current Issues in Pharmacy and Medical Sciences;2022-12-01
3. Meta-Analysis of Placebo-Controlled Trials of Levosimendan in Acute Myocardial Infarction;Journal of Cardiovascular Development and Disease;2021-10-07
4. Effects of different doses of levosimendan combined with Shenmai injection on immune function and galectin-3 and HSP70 levels in rats with acute heart failure;All Life;2021-01-01
5. Discovery and characterization of ORM‐11372, a novel inhibitor of the sodium‐calcium exchanger with positive inotropic activity;British Journal of Pharmacology;2020-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3